1.20% -0.025

Longeveron Inc (LGVN)

Longeveron Inc (LGVN) 最新ニュース

Longeveron Inc (LGVN)

Longeveron Inc (LGVN) 最新ニュース

Drug Maker Sued For Allegedly Concealing Drug’s Adverse Phase 2 Trial Results - Law360

Longeveron Inc [LGVN] Investment Guide: What You Need to Know - Knox Daily

Longeveron Inc (LGVN)’s stock price range in the last year - US Post News

Why has Longeveron stock tripled in two days? - MSN

Longeveron Inc’s Market Journey: Closing Weak at 1.97, Down -8.80 - The Dwinnex

LGVN’s Stock Market Adventure: -85.51% YTD Growth Amidst Volatility - The InvestChronicle

Insider Buying: Hare Joshua, Longeveron Inc [LGVN] Chief Scientific Officer invested 106,383 shares - Knox Daily

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire Inc.

Longeveron’s (LGVN) Buy Rating Reaffirmed at HC Wainwright - Defense World

H.C. Wainwright maintains Buy on Longeveron stock, notes positive FDA alignment - Investing.com Canada

H.C. Wainwright maintains Buy on Longeveron stock, notes positive FDA alignment - Investing.com

Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in - Daily Guardian Canada

Longeveron® Announces Positive Type C Meeting with U.S. FDA - GlobeNewswire

Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS) - Yahoo Finance

Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS) - StockTitan

Longeveron Inc’s latest rating changes from various analysts - Knox Daily

Ratio Analysis: Unpacking Longeveron Inc (LGVN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Longeveron Inc [NASDAQ: LGVN] Sees Decrease in Stock Value - Knox Daily

InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces Participation at H.C. Wainwright 26th Annual Global Investment Conference - MSN

Taking on analysts’ expectations and winning: Longeveron Inc (LGVN) - SETE News

Longeveron (NASDAQ:LGVN) Price Target Cut to $6.00 by Analysts at Maxim Group - Defense World

Beyond The Numbers: 4 Analysts Discuss Longeveron Stock - Benzinga

Reviewing MoonLake Immunotherapeutics (NASDAQ:MLTX) and Longeveron (NASDAQ:LGVN) - Defense World

Longeveron Inc (LGVN) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Longeveron to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024 - Marketscreener.com

LGVNLongeveron Inc. Latest Stock News & Market Updates - StockTitan

Longeveron Inc (LGVN) Becoming More Attractive for Investors - Knox Daily

Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com

Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Is Longeveron Inc (LGVN) worth investing in despite its undervalued state? - US Post News

Daily Market Movement: Longeveron Inc (LGVN) Sees a -2.28 Decrease, Closing at 2.57 - The Dwinnex

Longeveron Inc (LGVN) Stock: A Year of Market Fluctuations - The InvestChronicle

A company insider recently bought 106,383 shares of Longeveron Inc [LGVN]. Should You Buy? - Knox Daily

Take off with Longeveron Inc (LGVN): Get ready for trading - SETE News

Can you now get a good deal on Longeveron Inc’s shares? - US Post News

A Guide To The Risks Of Investing In Longeveron Inc (LGVN) - Knox Daily

Ratios in Focus: Analyzing Longeveron Inc (LGVN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Longeveron Inc. Expected to Post Q3 2024 Earnings of ($0.51) Per Share (NASDAQ:LGVN) - Defense World

Longeveron (NASDAQ:LGVN) Stock Rating Reaffirmed by HC Wainwright - Defense World

Longeveron Inc (LGVN) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle

Earnings call: Longeveron reports progress on Lomecel-B, eyes FDA talks - Investing.com India

Earnings call: Longeveron reports progress on Lomecel-B, eyes FDA talks - Investing.com

Earnings call: Longeveron reports progress on Lomecel-B, eyes FDA talks - Investing.com UK

Longeveron Inc. (NASDAQ:LGVN) Q2 2024 Earnings Call Transcript - Insider Monkey

Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update - BioSpace

Earnings call: Longeveron reports progress on Lomecel-B, eyes FDA talks - Investing.com Canada

LGVN Stock Earnings: Longeveron Misses EPS, Beats Revenue for Q2 2024 - InvestorPlace

Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update - StockTitan

Healthy Upside Potential: Longeveron Inc (LGVN) - SETE News

Recent Insider Activity Suggests Potential Gains for Longeveron Inc (LGVN) - Knox Daily

Longeveron Inc’s results are impressive - US Post News

Analytical Lens: Exploring Longeveron Inc (LGVN)’s Financial Story Through Ratios - The Dwinnex

Longeveron announces launch of contract development and manufacturing business - MSN

Insider Buying: Hare Joshua, Longeveron Inc [LGVN] Chief Scientific Officer invested 42,553 shares - Knox Daily

Longeveron Inc (LGVN) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

Longeveron (LGVN) Scheduled to Post Quarterly Earnings on Wednesday - Defense World

An analyst sees good growth prospects for Longeveron Inc (LGVN) - SETE News

The Potential Rise in the Price of Longeveron Inc (LGVN) following insiders activity - Knox Daily

Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024 - Marketscreener.com

Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024 - StockTitan

Deeper Dive: Understanding Longeveron Inc (LGVN) Through its Various Ratios - The Dwinnex

The Top 3 Small-Cap Stocks to Buy Now: Summer 2024 - InvestorPlace

Longeveron Inc. (NASDAQ:LGVN) to Post Q2 2024 Earnings of ($1.12) Per Share, HC Wainwright Forecasts - Defense World

What is Longeveron Inc (LGVN) Stock Return on Shareholders’ Capital? - SETE News

Longeveron stock target cut, maintains rating on FDA designations By Investing.com - Investing.com Canada

Longeveron stock target cut, maintains rating on FDA designations By Investing.com - Investing.com Nigeria

Longeveron stock target cut, maintains rating on FDA designations - Investing.com

Longeveron stock target cut, maintains rating on FDA designations - Investing.com India

Longeveron Inc (LGVN) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

LGVNに似た銘柄